AnalystsEd ArceEd Arce's Stock Forecasts
AnalystsEd Arce
Analyst Ranking
Top 8%
#316 out of 4204 analysts
Average Return
+7.26%
Win Rate
40%48 out of 121
Risk vs Reward
Poor
Good
Ed Arce's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cymabay Therapeutics IncCBAY | +431.28% | $1.79 | $9.51 | 2022-05-16 - 2023-03-20 | Buy |
Viking Therapeutics IncVKTX | +350.00% | $2.74 | $12.33 | 2017-11-10 - 2018-11-09 | Buy |
Cidara Therapeutics IncCDTX | +284.78% | $0.46 | $1.77 | 2022-05-12 - 2023-03-20 | Buy |
89bio IncETNB | +237.93% | $3.48 | $11.76 | 2022-07-28 - 2023-03-20 | Buy |
Unicycive Therapeutics IncUNCY | +231.82% | $0.66 | $2.19 | 2022-11-28 - 2023-03-20 | Buy |
Ed Arce Analyst Color
Get additional color on Ed Arce's coverage of popular stocks
Ed Arce's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
89bio IncETNB | 5 | Buy | $25.00 | +112.59% | Maintains | 2 days ago |
Pliant Therapeutics IncPLRX | 3 | Buy | $54.00 | +95.30% | Maintains | 2 days ago |
Akero Therapeutics IncAKRO | 8 | Buy | $64.00 | +67.93% | Reiterates | 2 days ago |
Paratek Pharmaceuticals IncPRTK | 6 | Buy | $10.00 | +629.93% | Maintains | 2 days ago |
Arbutus Biopharma CorpABUS | 5 | Buy | $6.00 | +98.68% | Reiterates | 2 days ago |
Cymabay Therapeutics IncCBAY | 4 | Buy | $12.00 | +26.18% | Maintains | 2 days ago |
Acurx Pharmaceuticals IncACXP | 2 | Buy | $14.00 | +357.52% | Reiterates | 5 days ago |
Mirum Pharmaceuticals IncMIRM | 9 | Buy | $61.00 | +158.47% | Reiterates | 7 days ago |
Akebia Therapeutics IncAKBA | 6 | Hold | $1.25 | +84.64% | Reiterates | 12 days ago |
Unicycive Therapeutics IncUNCY | 3 | Buy | $8.00 | +265.30% | Reiterates | 13 days ago |
Durect CorpDRRX | 2 | Buy | $32.00 | +588.17% | Maintains | 14 days ago |
Galectin Therapeutics IncGALT | 4 | Buy | $11.00 | +452.76% | Reiterates | 19 days ago |
Cidara Therapeutics IncCDTX | 5 | Buy | $6.50 | +267.23% | Reiterates | 21 days ago |
Chinook Therapeutics IncKDNY | 2 | Buy | $31.00 | +40.59% | Reiterates | 22 days ago |
Travere Therapeutics IncTVTX | 7 | Buy | $40.00 | +90.66% | Reiterates | a month ago |
Albireo Pharma IncALBO | 7 | Hold | $42.00 | -4.87% | Reiterates | a month ago |
Vera Therapeutics IncVERA | 3 | Buy | $15.00 | +100.53% | Maintains | 3 months ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $82.00 | +110.26% | Assumes | 3 months ago |
Terns Pharmaceuticals IncTERN | 2 | Hold | $7.00 | -29.15% | Maintains | 3 months ago |
Madrigal Pharmaceuticals IncMDGL | 6 | Buy | $225.00 | -12.09% | Maintains | 3 months ago |
Axcella Health IncAXLA | 4 | Hold | N/A | N/A | Downgrades | 3 months ago |
Enanta Pharmaceuticals IncENTA | 1 | Buy | $56.00 | +34.20% | Initiates Coverage On | 3 months ago |
Intercept Pharmaceuticals IncICPT | 6 | Hold | $14.00 | -6.91% | Maintains | 4 months ago |
Aurinia Pharmaceuticals IncAUPH | 6 | Buy | $14.00 | +51.84% | Maintains | 4 months ago |
Inventiva SaIVA | 3 | Buy | $36.00 | +742.89% | Maintains | 6 months ago |
Mimecast LtdMIME | 1 | Buy | $69.00 | -13.66% | Maintains | 10 months ago |
Arcturus Therapeutics Holdings IncARCT | 5 | Hold | $19.00 | +23.78% | Maintains | 10 months ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Acelrx Pharmaceuticals IncACRX | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Entasis Therapeutics Holdings IncETTX | 3 | Hold | $1.80 | N/A | Downgrades | a year ago |
Genfit SaGNFT | 3 | Buy | $8.00 | N/A | Upgrades | a year ago |
Dicerna Pharmaceuticals IncDRNA | 6 | Hold | $38.25 | N/A | Downgrades | a year ago |
Metacrine IncMTCR | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Assembly Biosciences IncASMB | 1 | Hold | $3.50 | N/A | Initiates Coverage On | 2 years ago |
Iterum Therapeutics PLCITRM | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Nabriva Therapeutics PLCNBRV | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Trevena IncTRVN | 3 | Hold | $0.75 | N/A | Downgrades | 4 years ago |
Tetraphase Pharmaceuticals IncTTPH | 2 | Buy | $7.00 | N/A | Maintains | 5 years ago |
Avenue Therapeutics IncATXI | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 5 years ago |
Viking Therapeutics IncVKTX | 1 | Buy | $7.00 | N/A | Assumes | 5 years ago |
Ocera Therapeutics IncOCRX | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Collegium Pharmaceutical IncCOLL | 1 | Buy | $21.00 | N/A | Initiates Coverage On | 6 years ago |
Atea Pharmaceuticals IncAVIR | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Medicines CoMDCO | 1 | Buy | $57.00 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.